Vir Biotechnology Inc (VIR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -395,064 | -231,923 | -120,965 | -521,960 | -417,371 |
| Depreciation Amortization | 16,707 | 12,394 | 6,956 | 19,956 | 14,902 |
| Income taxes - deferred | N/A | 59 | N/A | -2,949 | N/A |
| Accounts receivable | N/A | N/A | N/A | -6,513 | N/A |
| Accounts payable and accrued liabilities | 2,042 | 7,444 | -1,415 | -988 | 948 |
| Other Working Capital | -19,603 | 998 | 26,059 | -84,007 | -66,321 |
| Other Operating Activity | 30,013 | 12,693 | 11,249 | 150,109 | 109,125 |
| Operating Cash Flow | $-365,905 | $-198,335 | $-78,116 | $-446,352 | $-358,717 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 227,841 | 187,115 | 128,166 | 503,296 | 363,019 |
| PPE Investments | -4,121 | -3,841 | -1,348 | -3,929 | -4,389 |
| Investing Cash Flow | $223,720 | $183,274 | $126,818 | $499,367 | $358,630 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | N/A | N/A | -165 | N/A |
| Common Stock Issued | 3,105 | 3,004 | 598 | 4,553 | 3,303 |
| Other Financing Activity | -359 | -360 | 0 | 0 | -178 |
| Financing Cash Flow | $2,746 | $2,644 | $598 | $4,388 | $3,125 |
| Beginning Cash Position | 318,695 | 318,695 | 318,695 | 261,292 | 261,292 |
| End Cash Position | 179,256 | 306,278 | 367,995 | 318,695 | 264,330 |
| Net Cash Flow | $-139,439 | $-12,417 | $49,300 | $57,403 | $3,038 |
| Free Cash Flow | |||||
| Operating Cash Flow | -365,905 | -198,335 | -78,116 | -446,352 | -358,717 |
| Capital Expenditure | -4,484 | -4,167 | -1,629 | -7,301 | -5,306 |
| Free Cash Flow | -370,389 | -202,502 | -79,745 | -453,653 | -364,023 |